Hsa_circ_0001859通过miRNA-101-3p/MMP1轴促进NSCLC的进展
Jianxin Tan1, Zhenyu Fan2, Rongguo Lu1
1Lung Transplant Center, Department of Thoracic Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, China.
Frontiers in oncology
|July 16, 2025
概括
循环RNAcirc_0001859促进非小细胞肺癌 (NSCLC) 的生长和转移,通过海绵化miR-101-3p和上调MMP1. 这项研究揭示了circ_0001859作为NSCLC的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 非小细胞肺癌 (NSCLC) 在中国是一个重大的健康负担,许多患者在晚期被诊断出来.
- 在NSCLC病变发生过程中,外形圆形RNAcirc_0001859的特定作用仍然在很大程度上未被描述.
研究的目的:
- 研究circ_0001859在非小细胞肺癌中的功能和调节机制.
- 探索circ_0001859作为NSCLC的预后指标和治疗点的潜力.
主要方法:
- 定量实时聚合酶连锁反应 (qRT-PCR) 和西部分离被用于评估基因和蛋白质表达.
- 进行了细胞增殖,迁移和入侵试验 (CCK-8,殖民地形成,transwell).
- 路西法酶报告员,RNA免疫沉降 (RIP) 测试,以及体内异种移植模型被用来阐明分子机制.
主要成果:
- Circ_0001859在NSCLC组织和细胞中显著过度表达.
- 沉默circ_0001859抑制了NSCLC细胞的增殖,迁移和入侵.
- Circ_0001859作为miR-101-3p的分子海绵,调节MMP1表达并促进NSCLC的进展.
结论:
- Circ_0001859通过miR-101-3p/MMP1通路促进NSCLC的生长和转移.
- 这项研究提供了第一次详细调查circ_0001859在NSCLC中的作用和机制.
- Circ_0001859代表了一个有前途的预后生物标志物和NSCLC的治疗标.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K


